InnoCan Pharma Corporation (CSE:INNO)
Canada · Delayed Price · Currency is CAD 6.58
-0.08 (-1.20%)
Apr 10, 2026, 11:26 AM EST
InnoCan Pharma Revenue
In the year 2025, InnoCan Pharma had annual revenue of $26.61M USD, down -9.60%. InnoCan Pharma had revenue of $4.99M in the quarter ending December 31, 2025, a decrease of -7.65%.
Revenue
$26.61M
Revenue Growth
-9.60%
P/S Ratio
0.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.60M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.61M | -2.83M | -9.60% |
| Dec 31, 2024 | 29.44M | 15.78M | 115.55% |
| Dec 31, 2023 | 13.66M | 11.10M | 433.69% |
| Dec 31, 2022 | 2.56M | 2.36M | 1,205.61% |
| Dec 31, 2021 | 196.00K | 188.00K | 2,350.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| George Weston | 64.51B |
| Loblaw Companies | 63.90B |
| Metro | 22.18B |
| Dollarama | 7.26B |
| Swiss Water Decaffeinated Coffee | 258.72M |
| Inter-Rock Minerals | 146.18M |
| The Fresh Factory B.C. | 59.02M |
| Global Education Communities | 29.16M |
InnoCan Pharma News
- 11 days ago - Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M - PRNewsWire
- 6 weeks ago - FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time - PRNewsWire
- 2 months ago - Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs - PRNewsWire
- 2 months ago - Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering - PRNewsWire
- 2 years ago - Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million - GlobeNewsWire
- 3 years ago - Innocan Pharma Announces Launch of CBD Veterinary Commercialization Team - Newsfile Corp
- 3 years ago - Innocan Pharma Announces First Patent Grant in the United States - Newsfile Corp
- 3 years ago - Innocan Pharma Reports Clinical Success in Canine Compassionate Care Trial - Newsfile Corp